NEW YORK (GenomeWeb News) – Qiagen said today that it has acquired Corbett Life Science, a privately held life sciences instrumentation firm based in Sydney, Australia, in a transaction worth up to $135 million.
 
Under the terms of the agreement, Qiagen said it will pay approximately $66 million in cash, $4 million in restricted common stock and milestone payments, and “other contingencies” of up to $65 million over the next four years.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.